Have a personal or library account? Click to login

References

  1. 1. Freed LA, Benjamin EJ, Levy D, et al. Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study. Journal of the American College of Cardiology 2002; 40: 1298-304.10.1016/S0735-1097(02)02161-7
  2. 2. Zemtsovsky, E.V., Malev, E.G. (2012). Small heart anomalies and dysplastic phenotypes. SPb Russia: Publishing house “ИВЭСЭП”.
  3. 3. Levine RA, Hagége AA, Judge DP, et al. Mitral valve disease - morphology and mechanisms//Nat Rev Cardiol 2015 Dec; 12(12): 689-710.10.1038/nrcardio.2015.161
  4. 4. Bonow RO, Carabello BA, Chatterjee K, et al. R.O. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2008; 52: e1-142.
  5. 5. Stoddard MF, Prince CR, Dillon S, et al. Exercise-induced mitral regurgitation is a predictor of morbid events in subjects with mitral valve prolapse. J Am Col Cardiol 1995; 25(3): 693-699.10.1016/0735-1097(94)00408-I
  6. 6. Basso C, Marra MP, Rizzo S, et al. Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death. Circulation 2015; DOI: 10.1161/CIRCULATIONAHA.115.016291.10.1161/CIRCULATIONAHA.115.016291
  7. 7. Narayanan K, Uy-Evanado A, Teodorescu C, et al. Mitral Valve Prolapse and Sudden Cardiac Arrest in the Community. Heart Rhythm 2016; 13(2): 498-503.10.1016/j.hrthm.2015.09.026
  8. 8. Zeana CD. Recent data on mitral valve prolapse and magnesium deficit. Magnes-Res 1998; 1(3-4): 203-11.
  9. 9. Svanishvili T. Degree of correlation between cardiac auscultatory and echocardiographic findings among young athletes. European Heart Journal 2013; 34 (Suppl. 1): 5773.10.1093/eurheartj/eht310.P5773
  10. 10. Wayne, A.M. (2003). Vegetative disorders: clinic, diagnosis, treatment. M Russia: Medical Information Agency.
  11. 11. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart Rate Variability. Standards of Measurement, Physiological Interpretation and Clinical Use. Circulation 1996; 93: 1043-1065.
  12. 12. Baevsky, R.M., Kirillov, O.I., Kletskin, S.Z. (1984). Mathematical analysis of cardiac rhythm changes under stress. M: Russia.
  13. 13. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63: 2438-2488.10.1016/j.jacc.2014.02.537
  14. 14. Gromova O. Molecular mechanisms of magnesium action on connective tissue dysplasia. Dysplasia of connective tissue 2008; 1: 23-32.
  15. 15. Bobkowski W, Nowak A, Durlach J. The importance of magnesium status in the pathophysiology of mitral valve prolapse. Z Magnes Res 2005; 18(l): 35-52.
  16. 16. Lichodziejewska B, Klos J, Rezler J. Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Amer J Cardiol 2007; 79(6): 768-772.10.1016/S0002-9149(96)00865-X
  17. 17. Delling FN, Vasan RS. Epidemiology and Pathophysiology of Mitral Valve Prolapse: New Insights into Disease Progression, Genetics, and Molecular Basis. Circulation 2014; 129(21): 2158-2170.10.1161/CIRCULATIONAHA.113.006702405275124867995
  18. 18. Malpas SC. Neural influeces on cardiovascular variability: possibilities and pitfalls. Amer Physiol Soc 2002; 282(1): 6-20.
  19. 19. Bigger JT Identification of patients high risk for sudden cardiac death. Am J Cardiol 1992; 54(14): 3-8.
  20. 20. Abdullaev RF, Relfgat EB, Babayev ZM. Heart rate disturbances and QT interval changes in the mitral valve prolapse syndrome. Cardiology 1991; 12: 74-76.
  21. 21. Kupriyanova OO, Domnitskaya TM, Domnitsky MV, Dyachenko AV. Clinical significance of magnesium orotate application in adolescents with dysplasia of connective tissue of the heart. Cardiology 2005; 3:76-78.
  22. 22. Völger K.D., Mutschler E. Magnesium - ein überschätztes oder unterbewertetes Pharmakon? // Deutsche Apotheker Zeitung 1991; 13: 589-598.
  23. 23. Martynov AI, Akatova EV. Fifteen years experience of the use of magnesium preparations in patients with mitral valve prolapse. Kardiologiia 2011; 51(6): 60-5.
  24. 24. Amoozgar H, Rafizadeh H, Ajami G, Borzoee M. The Prevalence of Hypomagnesaemia in Pediatric Patients with Mitral Valve Prolapse Syndrome and the Effect of Mg Therapy. Int Cardiovasc Res J 2012; 6(3): 92-95.
  25. 25. Spielberger CD, Gorsuch RL, Lushene R. Manual for State-Trait Anxiety Inventory. Consulting Psychologist Press, California, USA, 1970
  26. 26. Khanin ro..H. Khanin Yu.L. Quick guide for the use of the scale of reactive and personal anxiety of Spielberg. Leningrad, Leningrad Institute of Physical Culture, 1976. P. 18 (in Russian).
DOI: https://doi.org/10.2478/sjecr-2019-0026 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Language: English
Page range: 107 - 115
Submitted on: May 15, 2019
Accepted on: Jun 4, 2019
Published on: Aug 5, 2021
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2021 Oleksandr Bilovol, Iryna Kniazkova, Bogun Maryna, Vladyslav Mishchenko, Oleksandr Tsihankov, Viktor Mazii, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.